Literature DB >> 10939540

Crescentic glomerulonephritis with positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase associated with autoimmune hemolytic anemia and thrombocytopenic purpura.

J Ohhashi1, M Miyamoto, S Ishikawa, Y Hashizume, T Nishido, K Matsuyama, K Morino, Y Miyazaki.   

Abstract

A 41-year-old woman was admitted to the hospital with severe uremia, hemolytic anemia, and thrombocytopenic purpura. Emergency hemodialysis with plasmapheresis was started in view of consideration of hemolytic uremic syndrome (HUS), which resulted in improvement of renal function and platelet count. Positive antineutrophil cytoplasmic autoantibody specific for myeloperoxidase (MPO-ANCA) suggested crescentic glomerulonephritis, which was pathologically evidenced by renal biopsy. The diagnosis of MPO-ANCA associated crescentic glomerulonephritis with autoimmune hemolytic anemia (AIHA) and thrombocytopenic purpura were confirmed. Three courses of steroid pulse therapy with heparin were successfully performed, followed by oral prednisolone and warfarin. Such a case has not been previously reported to our knowledge.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10939540     DOI: 10.2169/internalmedicine.39.650

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia.

Authors:  Yuki Hirai; Masayuki Iyoda; Takanori Shibata; Eijin Ashikaga; Nozomu Hosaka; Hiroki Suzuki; Hisako Nagai; Masanori Mukai; Hirokazu Honda; Aki Kuroki; Kozo Kitazawa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2008-05-10       Impact factor: 2.801

2.  Extreme Thrombocytosis Presenting in Anti-Neutrophil Cytoplasmic Autoantibodies-Associated Crescentic Glomerulonephritis with Immune Complex Deposits: A Case Report.

Authors:  Zhang Xuemei; Diao Yongshu; Zhang Ling; Yang Yingying; Fu Ping
Journal:  Iran Red Crescent Med J       Date:  2016-04-25       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.